DOSE-RESPONSE ANALYSES OF EXPERIMENTAL CANCER DATA

REFERENCES

• Melnick R. L., Huff J., Chou B. J., Miller R. Carcinogenicity of 1,3-butadiene in C57BL/6 × C3H F1 mice at low exposure concentrations. Cancer Res. 1990; 50: 6592–6599
   PubMed Web of Science ®Google Scholar
• Portier C. J., Bailer A. J. Testing for increased carcinogenicity using a survival-adjusted quantal response test. Fundam. Appl. Toxicol. 1989; 12: 731–737
   PubMedGoogle Scholar
• Portier C. J., Hedges J. C., Hoel J. D. Age-specific models of mortality and tumor onset for historical control animals in the National Toxicology Program's carcinogenicity experiments. Cancer Res. 1986; 46: 4372–4378
   PubMed Web of Science ®Google Scholar
• Melnick R. L., Sills R. C., Portier C. J., Roycroft J. H., Chou B. J., Grumbein S. L., Miller R. A. Multiple organ carcinogenicity of inhaled chloroprene (2-chloro-1,3-butadiene) in F344 rats and B6C3F1 mice and comparison of dose-response with 1,3-butadiene in mice. Carcinogenesis 1999; 20: 867–878
   PubMed Web of Science ®Google Scholar
• Kohn M. C., Melnick R. L. Species differences in the production and clearance of butadiene metabolites: A mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis 1993; 14: 619–628
   PubMed Web of Science ®Google Scholar
• National Toxicology Program, Toxicology and carcinogenesis studies of isoprene (CAS No. 78-79-5) in F344/N rats (inhalation studies), Technical Report NTP-TR-486. NIH Publication No. 97-3976. National Institutes of Health, Research Triangle Park, NC, 1999, 1–176
   Google Scholar
• Melnick R. L., Kohn M. C., Dunnick J., Leininger J. R. Regenerative hyperplasia is not required for liver tumor induction in female B6C3F1 mice exposed to trihalomethanes. Toxicol. Appl. Pharmacol. 1998; 148: 137–147
   PubMed Web of Science ®Google Scholar
• Huff J. E., Melnick R. L., Solleveld H. A., Haseman J. K., Powers M., Miller R. A. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 1985; 227: 548–549
   PubMed Web of Science ®Google Scholar
• Fajen J. M., Roberts D. R., Ungers L. J., Krishnan E. R. Occupational exposure of workers to 1,3-butadiene. Environ. Health Perspect. 1990; 861: 11–18
   Google Scholar
• Bailer A. J., Portier C. J. Effects of treatment-induced mortality and tumor-induced mortality on tests for carcinogenicity in small samples. Biometrics 1988; 44: 417–431
   PubMed Web of Science ®Google Scholar
• Kohn M. C., Melnick R. L. Effects of the structure of a toxicokinetic model of butadiene inhalation exposure on computed production of carcinogenic intermediates. Toxicology 1996; 113: 31–39
   PubMed Web of Science ®Google Scholar
• Malvoisin E., Roberfroid M. Hepatic microsomal metabolism of 1,3-butadiene. Xenobiotica 1982; 12: 137–144
   PubMed Web of Science ®Google Scholar
• Csanády G. A., Guengerich F. P., Bond J. A. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats, and mice. Carcinogenesis 1992; 13: 1143–1153
   PubMed Web of Science ®Google Scholar
• de Meester C., Poncelet F., Roberfroid M., Mercier M. The mutagenicity of butadiene towards Salmonella typhimurium. Toxicol. Lett. 1980; 6: 125–130
   PubMed Web of Science ®Google Scholar
• de Meester C., Poncelet F., Roberfroid M., Mercier M. Mutagenicity of butadiene and butadiene monoxide. Biochem. Biophys. Res. Commun. 1978; 80: 298–305
   PubMed Web of Science ®Google Scholar
• Wade M. J., Moyer J. W., Hine C. H. Mutagenic action of a series of epoxides. Mutat. Res. 1979; 66: 367–371
   PubMed Web of Science ®Google Scholar
• International Agency for Research on Cancer, 1,3-Butadiene. Evaluation of Carcinogenic Risks to Humans, Occupational Exposures to Mists and Vapours from Strong Inorganic Acids; and other Industrial Chemicals. IARC Monograph, IARC, Lyon 1992; 54: 237–285
   Google Scholar
• Melnick R. L., Sills R. C., Roycroft J. H., Chou B. J., Ragan H. A., Miller R. A. Isoprene, an endogenous hydrocarbon and industrial chemical, induces multiple organ neoplasia in rodents after 26 weeks of inhalation exposure. Cancer Res. 1994; 54: 5333–5339
   PubMed Web of Science ®Google Scholar
• Gervasi P. G., Longo V. Metabolism and mutagenicity of isoprene. Environ. Health Perspect. 1990; 86: 85–87
   PubMed Web of Science ®Google Scholar
• Dunnick J. K., Melnick R. L. Assessment of the carcinogenic potential of chlorinated water: Experimental studies of chlorine, chloramine, and trihalomethanes. J. Natl. Cancer Inst. 1993; 85: 817–822
   PubMed Web of Science ®Google Scholar
• Larson J. L., Wolf D. C., Butterworth B. E. Induced cytotoxicity and cell proliferation in the hepatocarcinogenicity of chloroform in female B6C3F1 mice: Comparison of administration by gavage in corn oil vs ad libitum in drinking water. Fundam. Appl. Toxicol. 1994; 22: 90–102
   PubMedGoogle Scholar
• Larson J. L., Wolf D. C., Butterworth B. E. Induced regenerative cell proliferation in livers and kidney of male F-344 rats given chloroform in corn oil by gavage or ad libitum in drinking water. Toxicology 1995; 95: 73–86
   PubMed Web of Science ®Google Scholar
• Larson J. L., Wolf D. C., Méry S., Morgan K. T., Butterworth B. E. Toxicity and cell proliferation in the liver, and kidneys and nasal passages of female F-344 rats induced by chloroform administered by gavage. Food. Chem. Toxicol. 1995; 33: 443–456
   PubMed Web of Science ®Google Scholar
• Jorgenson T. A., Meierhenry E. F., Rushbrook C. J., Bull R. J., Robinson M. Carcinogenicity of chloroform in drinking water to male Osborne–Mendel rats and female B6C3F1 mice. Fundam. Appl. Toxicol. 1985; 5: 760–769
   PubMedGoogle Scholar